Seroatlas · Human Serome Atlas

DNAAF19

Dynein axonemal assembly factor 19

Also known as: CCDC103, CILD17, DAA19_HUMAN, FLJ13094, FLJ34211, PR46b

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q8IW40
Gene
DNAAF19
Ensembl
ENSG00000167131
Chromosome
17
Canonical length
242 aa
Protein class
Disease related genes, Human disease related genes, Predicted intracellular proteins
Subcellular location
Cytosol,Connecting piece,Mid piece
Quaternary structure
Homodimer

OverviewNCBI Gene

Enables protein homodimerization activity. Involved in axonemal dynein complex assembly; cilium movement; and determination of left/right symmetry. Predicted to be located in axoneme. Predicted to be part of outer dynein arm. Implicated in primary ciliary dyskinesia 17. [provided by Alliance of Genome Resources, Jul 2025]

Canonical amino-acid sequenceUniProt

242 residues, UniProt reviewed canonical sequence.

>Q8IW40|DNAAF19
     1  MERNDIINFK ALEKELQAAL TADEKYKREN AAKLRAVEQR VASYEEFRGI VLASHLKPLE
    61  RKDKMGGKRT VPWNCHTIQG RTFQDVATEI SPEKAPLQPE TSADFYRDWR RHLPSGPERY
   121  QALLQLGGPR LGCLFQTDVG FGLLGELLVA LADHVGPADR AAVLGILCSL ASTGRFTLNL
   181  SLLSRAERES CKGLFQKLQA MGNPRSVKEG LSWEEQGLEE QSGGLQEEER LLQELLELYQ
   241  VD

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against DNAAF19 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.43
Highest tissue expression
39 nTPM

Expression across tissuesHPA

Tissue

  • testis: 39 nTPM
  • fallopian tube: 23 nTPM
  • choroid plexus: 6.4 nTPM
  • retina: 3.8 nTPM
  • cerebral cortex: 3.4 nTPM
  • thyroid gland: 3.4 nTPM

Single-cell type

  • epicardial cells: 18 nCPM
  • ependymal cells: 16 nCPM
  • cardiomyocytes: 7.4 nCPM
  • late spermatids: 4.2 nCPM
  • choroid plexus epithelial cells: 3.1 nCPM
  • adipocytes: 2.5 nCPM

Immune cell

  • classical monocyte: 2 nTPM
  • eosinophil: 1.6 nTPM
  • myeloid DC: 1.4 nTPM
  • total PBMC: 1.3 nTPM
  • intermediate monocyte: 1.1 nTPM
  • non-classical monocyte: 0.8 nTPM

Brain region

  • midbrain: 12 nTPM
  • medulla oblongata: 9.5 nTPM
  • choroid plexus: 8.5 nTPM
  • spinal cord: 7.1 nTPM
  • thalamus: 7.1 nTPM
  • pons: 6.9 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about DNAAF19.

Disease | AllUniProt

Conditions DNAAF19 is implicated in, by any mechanism.

Disease | GeneticClinVar

26 pathogenic / likely-pathogenic of 200 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.36
gnomAD pLI
0
DepMap mean gene effect
0.06
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of DNAAF19 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads DNAAF19 as an antibody target. Whether an autoantibody or antibody against DNAAF19 could matter depends on whether native DNAAF19 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

DNAAF19 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label DNAAF19 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/DNAAF19. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...